Literature DB >> 19038260

Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.

Jenna E Ryan1, Neelam Dhiman, Inna G Ovsyannikova, Robert A Vierkant, V Shane Pankratz, Gregory A Poland.   

Abstract

Feasibility, amount of sample aliquots, processing time and cost are critical considerations for optimizing and conducting assays for large-population based studies. Well designed statistical approaches that quickly identify optimal conditions for a given assay could assist efficient completion of the laboratory assays for such studies. For example, assessment of the profile of secreted cytokines is important in understanding the immune response after vaccination. To characterize the cytokine immune response following smallpox vaccination, PBMC obtained from recently vaccinated subjects were stimulated with varying doses of live or UV-inactivated vaccinia virus and cultured for up to 8 days. In this paper, we describe a novel statistical method to identify optimal operating conditions for length in culture and virus MOI in order to measure a panel of secreted Th1, Th2, and inflammatory cytokines. This statistical method is comprised of two components. It first identifies a subset of the possible time in culture by virus MOI combinations to be studied. It then utilizes response surface analysis techniques to predict the optimal operating conditions for the measurement of each secreted cytokine. This method was applied, and the predicted optimal combinations of length in culture and virus MOI for maximum vaccinia-specific cytokine secretion were identified. The use of the response surface methodology can be applied to the optimization of other laboratory assays; especially when the number of PBMC available limits the testing of all possible combinations of parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038260      PMCID: PMC2835303          DOI: 10.1016/j.jim.2008.11.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  Duration of antiviral immunity after smallpox vaccination.

Authors:  Erika Hammarlund; Matthew W Lewis; Scott G Hansen; Lisa I Strelow; Jay A Nelson; Gary J Sexton; Jon M Hanifin; Mark K Slifka
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

2.  Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

Authors:  Jeffrey S Kennedy; Sharon E Frey; Lihan Yan; Alan L Rothman; John Cruz; Frances K Newman; Laura Orphin; Robert B Belshe; Francis A Ennis
Journal:  J Infect Dis       Date:  2004-08-30       Impact factor: 5.226

3.  Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon; S J Kirsch; H S Warren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

5.  Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

Authors:  Frances K Newman; Sharon E Frey; Tamara P Blevins; Mahendra Mandava; Andres Bonifacio; Lihan Yan; Robert B Belshe
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Authors:  Kathleen H Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James W Leduc; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

7.  Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Rawleigh C Howe; Jenna E Ryan; Robert M Jacobson; Gregory A Poland
Journal:  J Immunol Methods       Date:  2004-04       Impact factor: 2.303

8.  Optimal kinetics for quantification of antigen-induced cytokines in human peripheral blood mononuclear cells by real-time PCR and by ELISA.

Authors:  Slavka Listvanova; Stéphane Temmerman; Patrick Stordeur; Virginie Verscheure; Sammy Place; Lin Zhou; Camille Locht; Françoise Mascart
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

9.  Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models.

Authors:  Shih-Houng Young; James M Antonini; Jenny R Roberts; Aaron D Erdely; Patti C Zeidler-Erdely
Journal:  J Immunol Methods       Date:  2007-12-17       Impact factor: 2.303

10.  Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.

Authors:  Behazine Combadiere; Alexandre Boissonnas; Guislaine Carcelain; Evelyne Lefranc; Assia Samri; François Bricaire; Patrice Debre; Brigitte Autran
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  16 in total

1.  Genome-wide genetic associations with IFNγ response to smallpox vaccine.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2012-06-03       Impact factor: 4.132

2.  Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Authors:  Ann L Oberg; Neelam Dhiman; Diane E Grill; Jenna E Ryan; Richard B Kennedy; Gregory A Poland
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

3.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

4.  Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Authors:  Benjamin J Umlauf; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

5.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

6.  Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Gregory A Poland; Inna G Ovsyannikova; Ann L Oberg; Yan W Asmann; Diane E Grill; Robert A Vierkant; Robert M Jacobson
Journal:  Vaccine       Date:  2016-05-11       Impact factor: 3.641

7.  SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Authors:  Neelam Dhiman; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2010-03-10       Impact factor: 2.846

8.  Response surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells.

Authors:  Matthew J Taylor; Iana H Haralambieva; Robert A Vierkant; Inna G Ovsyannikova; Gregory A Poland
Journal:  J Immunol Methods       Date:  2012-06-13       Impact factor: 2.303

9.  Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.

Authors:  Pritish K Tosh; Richard B Kennedy; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

10.  Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Gene       Date:  2012-08-23       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.